SGS at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

SGS takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 228. Its program centres on early clinical development of products against RSV (respiratory syncytial virus). It covers streamlining the path from the first trial in people to a human challenge study that gives early proof a product works, the kind of early-stage work the company runs.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
sgs.com
CRO, CDMO & labs
Clinical research organization specializing in early-stage development and functional biometrics across Phases I–IV, with a presence in Europe and the Americas.
Booth
Exhibiting at Booth 228
Talk
Wed Oct 21
10:45
Streamline your RSV early development program from FIH to POC CHIM
Clinical Trials

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from SGS

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction